These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quality control and analytical techniques for biopharmaceuticals. Robinson CJ; Jones C Bioanalysis; 2011 Jan; 3(1):81-95. PubMed ID: 21175369 [TBL] [Abstract][Full Text] [Related]
3. Sound science versus anxiety: validation of bioanalytical assays for small molecules. Svensson LD Bioanalysis; 2011 Dec; 3(24):2685-9. PubMed ID: 22185264 [No Abstract] [Full Text] [Related]
6. Analytical performance specifications for changes in assay bias (Δbias) for data with logarithmic distributions as assessed by effects on reference change values. Petersen PH; Lund F; Fraser CG; Sölétormos G Ann Clin Biochem; 2016 Nov; 53(6):686-691. PubMed ID: 27147623 [TBL] [Abstract][Full Text] [Related]
7. Using the confidence interval of the mean to detect systematic errors in one analytical run. Asberg A; Bolann B; Mikkelsen G Scand J Clin Lab Invest; 2010 Oct; 70(6):410-4. PubMed ID: 20602577 [TBL] [Abstract][Full Text] [Related]
9. New section on standard method performance requirements. Rathbone R J AOAC Int; 2011; 94(4):45A. PubMed ID: 21919332 [No Abstract] [Full Text] [Related]
10. Rationale for using data on biological variation. Ricós C; Álvarez V; Perich C; Fernández-Calle P; Minchinela J; Cava F; Biosca C; Boned B; Doménech M; García-Lario JV; Simón M; Fernández PF; Diaz-Garzón J; González-Lao E Clin Chem Lab Med; 2015 May; 53(6):863-70. PubMed ID: 25928757 [TBL] [Abstract][Full Text] [Related]
11. Moving Average for Continuous Quality Control: Time to Move to Implementation in Daily Practice? van Rossum HH; Kemperman H Clin Chem; 2017 May; 63(5):1041-1043. PubMed ID: 28320760 [No Abstract] [Full Text] [Related]
12. Conference Report: Analytical challenges in the qualification and validation of pharmacodynamic biomarkers. Houghton R; Chamberlain J Bioanalysis; 2011 May; 3(9):945-8. PubMed ID: 21545341 [TBL] [Abstract][Full Text] [Related]
13. Incurred sample reanalysis: dilemma in its applicability - should it be practiced for all bioanalytical assays involving single (parent or metabolite) or multiple analytes (parent/metabolite or parent with co-administered drugs)? Srinivas NR Biomed Chromatogr; 2011 Jun; 25(6):737-9. PubMed ID: 21465501 [No Abstract] [Full Text] [Related]
15. The certainty of uncertainty. Horwitz W J AOAC Int; 2003; 86(1):109-11. PubMed ID: 12607748 [No Abstract] [Full Text] [Related]
16. The role of assay validation in specification development. Baffi RA Dev Biol Stand; 1997; 91():105-13. PubMed ID: 9413687 [TBL] [Abstract][Full Text] [Related]
17. What information on quality specifications should be communicated to clinicians, and how? Plebani M Clin Chim Acta; 2004 Aug; 346(1):25-35. PubMed ID: 15234633 [TBL] [Abstract][Full Text] [Related]
19. Incurred sample reanalysis: it is just a matter of good scientific practice. Kelley M Bioanalysis; 2011 May; 3(9):931-2. PubMed ID: 21545338 [No Abstract] [Full Text] [Related]
20. Validation of bioassays for quality control. Lansky D Dev Biol Stand; 1999; 97():157-68. PubMed ID: 10463541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]